Nerviano Medical Sciences - Part of NMS Group Revenue and Competitors
Estimated Revenue & Valuation
- Nerviano Medical Sciences - Part of NMS Group's estimated annual revenue is currently $9.7M per year.
- Nerviano Medical Sciences - Part of NMS Group's estimated revenue per employee is $102,000
Employee Data
- Nerviano Medical Sciences - Part of NMS Group has 95 Employees.
- Nerviano Medical Sciences - Part of NMS Group grew their employee count by 14% last year.
Nerviano Medical Sciences - Part of NMS Group's People
| Name | Title | Email/Phone |
|---|
Nerviano Medical Sciences - Part of NMS Group Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6M | 65 | -4% | N/A | N/A |
#2 | $11.5M | 113 | 2% | N/A | N/A |
#3 | $13.3M | 130 | 5% | N/A | N/A |
#4 | $9.7M | 95 | 14% | N/A | N/A |
#5 | $8M | 78 | 47% | N/A | N/A |
#6 | $6M | 65 | 12% | N/A | N/A |
#7 | $9.9M | 97 | 1% | N/A | N/A |
#8 | $48.7M | 382 | 9% | N/A | N/A |
#9 | $2.4M | 30 | 15% | N/A | N/A |
#10 | $3.3M | 41 | 0% | N/A | N/A |
What Is Nerviano Medical Sciences - Part of NMS Group?
Nerviano Medical Sciences is part of NMS Group and it is focused on the discovery and early development of oncology drugs. Our business model is to partner our drugs at late preclinical or early clinical stage for full development and commercialization. Our mission is to pursue innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action, for the advancement of personalized care of cancer patients. An experienced and lean management team leads a highly skilled staff of professionals with international experience and a broad range of expertise in R&D, combining the flexibility of a biotech with the quality standards of a big pharma.
keywords:N/A
N/A
Total Funding
95
Number of Employees
$9.7M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator